Home / Available CME / Individual Care Program

Individual Care Program

Indivd_Care_Static_Banner

Presented By:
JohnsHopkins_Logo

About the Program

Program Overview
Learning Objectives and Program Details
Intended Audience
Accreditation Statement
Credit Designation Statement
Course Directors
Faculty
Full Disclosure Policy Affecting CME Activities
Off-label Product Discussion
Method to Participate and Obtain Continuting Medical Education Credit
Request for Program Slides and Review

Program Overview

With more than 20 approved antiretrovirals (ARV) and 6 ARV classes, health care providers caring for HIV-positive patients have multiple choices regarding ARV therapy, even in patients with significant past antiretroviral experience and resistance. One of the most important challenges for health care providers is individualizing the care of their HIV-positive patients and to understand and utilize the data which indicate when certain ARV therapies and therapeutic strategies are appropriate, and when they are not. Numerous studies over the past 15 years have clearly demonstrated that ARV therapy must be specifically tailored to the individual and his or her abilities and needs.

This case-based roundtable discussion features Drs. Calvin Cohen, Ian Frank and Richard Elion as discussants and Dr. John Barlett as modoerator. The discussion will provide participants with knowledge regarding ARV therapies and therapeutic regimens that is needed to accomplish individualization of care, education regarding all important clinical trials to date that examine individualization of care issues, clinical insight into how expert HIV clinicians approach and manage individualization of care, and an opportunity to strengthen their expertise and ability to individualize care in the clinical setting.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity. This program is for health care providers who treat HIV-positive patients. It is tuition-free and there are no prerequisites.

Learning Objectives and Program Details

Upon completion of the program, participants should be able to:

Gain further knowledge regarding the importance of individualizing ARV therapy;
Explain the role individualizing ARV therapy has in improving treatment outcomes;
Explain and use in clinical settings the skills needed to gather knowledge regarding the patient and establish a trusting relationship that furthers the exchange of information between clinician and patient needed to accomplish individualization of care;
Apply in clinical practice the concepts important in individualizing ARV therapy including considering and weighing the characteristics of the ARV therapy options available and applying this knowledge to the characteristics of the individual patient to arrive at the optimal choice of ARV therapy for that individual.

Release Date: September 18, 2009
Expiration Date: September 18, 2010

Estimated time to complete this activity: 2 hours

Intended Audience

This activity is intended for physicians, physicians' assistants, advanced practice nurses, and other healthcare professionals involved in the treatment and management of patients with HIV infection. There are no prerequisites.

Accreditation Statement

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement

The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Course Directors

John Bartlett, MD
Professor of Medicine,
Johns Hopkins School of Medicine
Baltimore, Maryland

Calvin J. Cohen, MD, MS
Research Director, CRI New England
Clinical Instructor, Harvard Medical School
Boston, Massachusetts

Faculty

Richard A. Elion, MD
Associate Professor of Clincial Medicine,
George Washington University Medical Center
Washington, DC

Ian Frank, MD
Associate Professor of Medicine
Director, Antiretroviral Clinical Research,
University of Pennsylvania
Philadelphia, Pennsylvania

Full Disclosure Policy Affecting CME Activities

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any relevant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:

Dr. John Bartlett:

Sources of Funding for Research: None.
Consulting Agreements: Johnson & Johnson; Tibotec; Pfizer.
Honorarium Agreements: Abbott.
Speakrs' Bureau: None.
Financial Interests/Stock Ownership: None.
Other: None.

Dr. Calvin Cohen:

Sources of Funding for Research: GlaxoSmithKline; Bristol-Myers Squibb; Gilead; Tibotec; Pfizer; Merck & Co.; Tobira.
Consulting/Honorarium Agreements: GlaxoSmithKline; Bristol-Myers Squibb; Gilead; Tibotec; Pfizer; Merck & Co.; Tobira; Myriad.
Speakers' Bureau: GlaxoSmithKline; Bristol-Myers Squibb; Gilead; Tibotec; Pfizer; Merck & Co.
Financial Interests/Stock Ownership: None.
Other: None.

Dr. Richard A. Elion:

Sources of Funding for Research: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Tibotec; Tobira; Rapid Pharm
Consulting Agreements/Speakers' Bureau: Bristol-Myers Squibb; Gilead Sciences; Tibotec.
Honorarium Agreements: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Tibotec.
Financial Interests/Stock Ownership: None.
Other: None.

Dr. Ian Frank:

Sources of Funding for Research: Bavarian Nordic; Merck & Co.
Consulting Agreements: Abbott; Bristol-Myers Squibb; Gilead; Pfizer; Tibotec.
Speakers' Bureau/Honorarium Agreements: Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Pfizer; Tibotec.
Financial Interests/Stock Ownership: None.
Other: None.

Off-label Product Discussion

Drs. Bartlett, Cohen, Frank and Elion have disclosed that thier presentation will reference unlabelled/unapproved used of the following products: lopinavir/r, atazanavir, raltegravir, maraviroc, and etravirine

Method to Participate and Obtain Continuting Medical Education Credit

In order to receive credit, participants must view the entire activity and complete a post test and activity evaluation online. Upon a successful score of 70% on the post test and completion of the evaluation, participants may print out their certificate. Participants may access the program, post test and evaluation for this activity by clicking the link below:

Request for Program Slides and Review

To request a copy of the program slides as well as further education on how to use the slides please Click Here to fill out a content request form.

Opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME program. CME collects only the information necessary to provide you with the services that you request.

Share this page: